Takeda Pharmaceutical Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
47.88 | 111.03 | -56.87% | 44.56 | 7.46% |
| P/S |
|
1.62 | 75.03 | -97.84% |
|
|
| P/BV |
|
0.9483 | 70.29 | -98.65% |
|
|
| P/FCF |
|
42.8 | 80.52 | -46.85% |
|
|
| Ev/Ebitda |
|
9.99 | 76.71 | -86.97% |
|
|
| Ev/S |
|
2.65 | 72.43 | -96.35% |
|
|
| Ev/FCF |
|
70.71 | 15.5 | 356.27% |
|
|
| E/P |
|
0.0211 | 0.1179 | -82.1% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
26.48 | -78.2 | -133.87% | 27.89 | -5.04% |
| ROE |
|
1.98 | -10.46 | -118.94% |
|
|
| ROA |
|
0.9535 | -10.03 | -109.51% |
|
|
| ROIC |
|
5.63 | 9.09 | -38.11% |
|
|
| ROS |
|
3.38 | -143.89 | -102.35% |
|
|
| ROCE |
|
5.52 | 2.34 | 135.34% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
2/10
|
4.29 | 1.08 | 297.84% | 4.8 | -10.68% |
| Nеt Debt/Ebitda |
|
3.88 | -0.3908 | -1093.75% |
|
|
| Debt/Ratio |
|
0.3206 | 0.1308 | 145.04% |
|
|
| Debt/Equity |
|
2.86 | 6.92 | -58.62% |
|
|
| Debt/Net Income |
|
33.62 | -1.84 | -1925.78% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
6.79 | 2.62 | 158.7% | 6.09 | 11.51% |
| Number of years of dividend growth |
|
2 | 1.16 | 73.1% |
|
|
| DSI |
|
1 | 0.7238 | 38.16% |
|
|
| Average dividend growth |
|
1.06 | -10.93 | -109.67% |
|
|
| Average percentage for 5 years |
|
6.09 | 1.88 | 223.43% |
|
|
| Average percentage for payments |
|
190.34 | 37.94 | 401.73% |
|
|
| Difference from average difference in sector |
|
4.17 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
4/10
|
29.55 | 170.19 | -82.64% |
| Growth impulse Ebitda 5 years |
|
68.08 | 101.21 | -32.73% |
| Growth impulse Net Income 5 years |
|
225.64 | 82.55 | 173.34% |
| Growth impulse FCF 5 years |
|
-64.7 | 104.08 | -162.16% |
| Growth impulse EPS 5 years |
|
222.73 | 127.91 | 74.13% |
IP Score
5.33/10
